Hrt Financial LP Mimedx Group, Inc. Transaction History

Hrt Financial LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$5.7 - $9.14 $92,163 - $147,784	16,169 New	16,169 $141,000
Q2 2023 Aug 11, 2023	BUY	$3.14 - $6.61 $102,696 - $216,186	32,706 New	32,706 $216,000
Q2 2022 Aug 12, 2022	SELL	$3.17 - $5.0 $89,241 - $140,760	-28,152 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.27 - $6.27 $62,657 - $92,005	14,674 Added 108.87%	28,152 $132,000
Q4 2021 Feb 14, 2022	SELL	$5.7 - $8.48 $65,162 - $96,943	-11,432 Reduced 45.89%	13,478 $81,000
Q3 2021 Nov 15, 2021	BUY	$5.52 - $15.83 $137,503 - $394,325	24,910 New	24,910 $150,000
Q2 2021 Aug 16, 2021	SELL	$9.02 - $12.72 $254,544 - $358,958	-28,220 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.48 - $11.28 $239,305 - $318,321	28,220 New	28,220 $290,000

208

98.1M

65.3K

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $1.04B
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.